Do prophylactic coral dips affect healthy corals?

Do prophylactic coral dips leave a lasting biological cost? Klinges and colleagues (2023) followed healthy elkhorn and mountainous star coral after repeated exposure to Lugol’s solution or KoralMD. The bacterial communities showed no broad, persistent treatment pattern, but one growth result argues against treating every dip as biologically neutral.

Study at a glance: two sequential aquarium experiments at Mote Marine Laboratory compared treated and untreated fragments from two genotypes of each species. Microbiomes were sampled through 60 days after the final bath; coral surface area was tracked with 3D scans.

A mostly quiet microbiome result came with one growth warning.

The two products were tested in separate experiments on different fragments. The study examined healthy corals under a preventive schedule, not sick corals receiving treatment.

Many fragments do not equal many independent aquarium systems. Treated and untreated racks for a species shared one 170-L holding tank in each experiment, and the paper does not specify independent replication of the bath bins. That design controls the shared water environment, but it cannot estimate how treatment effects vary among tanks or bath batches.

What remains unresolved?

Strengths: The team used untreated comparisons, sampled five points from before exposure through the 60-day washout, tested a branching and a massive coral, and released the sequence data and analysis code.

Limits: Only two genotypes represented each species. The two products were run months apart rather than head-to-head, after different amounts of acclimation to a changed seawater source. A pump problem removed the final Lugol’s growth point for A. palmata. The single holding tank per species and unspecified bath-bin replication constrain causal inference beyond these systems.

Because the corals began healthy, the experiment cannot balance a possible treatment cost against any benefit to an infected or pest-bearing coral. It also did not test whether the detected bacterial changes altered microbial function.

What this means

Reef Cloverson interpretation: The absence of a broad microbiome disruption is reassuring within this protocol, but it is not a blanket safety certificate. The slower one-month growth of Lugol-treated A. palmata shows why survival alone can miss a husbandry cost.

A useful next step is to separate product, handling and system effects with independently repeated bath batches and holding units, then repeat the comparison on corals with a defined health problem. That would test benefit and cost in the same design.

Could we replicate this?

Published protocol: Healthy fragments of Acropora palmata and Orbicella faveolata received either the Lugol’s or KoralMD schedule described above. Controls skipped the antiseptic bath. Corals were maintained in roughly 170-L flow-through tanks near 300 µmol photons m⁻² s⁻¹ PAR, with one powerhead per tank and broadcast feeding three times weekly. Microbiome fragments were removed at baseline, after the first and sixth baths, and 30 and 60 days later. A 3D structured-light scanner measured a separate growth subset.

Proposed smaller pilot—not performed in the paper: Ask whether the one-month growth difference persists when bath handling is repeated independently. The manipulated variable would be dip versus matched seawater handling; untreated seawater baths would be the comparison. Independent bath batches or holding vessels—not the number of fragments within one shared vessel—would carry the treatment replication, with fragments from each genotype distributed across conditions. Random assignment was not reported in the paper and should be documented in an adaptation.

Essential equipment includes stable seawater vessels, calibrated timers and volumes, flow during the bath, a rinse station, controlled light and flow after treatment, and repeatable surface-area imaging. Microbiome sequencing is optional if the pilot question is limited to growth and survival. A small pilot could test workflow and detect a large short-term growth signal; it could not establish pest control, disease treatment, broad microbial safety or field performance.

U.S. research resource: the experiment was conducted at Mote Marine Laboratory’s Elizabeth Moore International Center for Coral Reef Research & Restoration in Summerland Key, Florida. The public paper, sequence archive and analysis repository provide protocol and data references; this does not imply access or collaboration.

Methods: How they did it

Summerland Key, Florida · November 2021 and May 2022 experiments · approximately 2.5 months each.

Funding source

The paper identifies Mote Marine Laboratory’s Protect Our Reefs Grant as the funder, under awards POR_2020_24 and POR_2021_007. Mote interns assisted with sampling and imaging, and staff at the Elizabeth Moore International Center supplied technical and logistical support; those contributions are acknowledged separately from the grants. The paper’s conflict statement reports no relevant commercial or financial ties. Read the paper’s funding, acknowledgments and conflict statements ↗

Sources

Klinges et al. (2023) · Frontiers in Marine Science · Full paper, methods, results and funding statement

Study repository · Public analysis scripts

NCBI BioProject PRJNA1022056 · Raw sequence-data record

Mote Marine Laboratory · Institutional author and publication record